Li Kang Biomedical Co., Ltd. (TPEX:6242)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
37.50
-0.20 (-0.53%)
May 20, 2026, 10:52 AM CST

Li Kang Biomedical Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
1,1991,2481,3641,5631,315872
Market Cap Growth
-15.85%-8.51%-12.69%18.87%50.69%5.93%
Enterprise Value
1,1421,1879961,4131,116788
Last Close Price
37.7039.2540.9152.9241.9627.00
PE Ratio
15.4714.8917.7214.0811.7316.96
PS Ratio
2.082.122.412.481.922.26
PB Ratio
1.361.431.602.482.311.77
P/TBV Ratio
1.361.431.602.492.311.77
P/FCF Ratio
--518.6216.728.4215.53
P/OCF Ratio
17.0013.5520.8716.158.3614.43
EV/Sales Ratio
1.982.021.762.251.632.04
EV/EBITDA Ratio
11.5211.099.929.887.5211.23
EV/EBIT Ratio
12.4812.0811.0610.598.1213.76
EV/FCF Ratio
-4.69-378.3915.127.1514.02
Debt / Equity Ratio
0.140.140.110.14-0.07
Debt / EBITDA Ratio
1.271.180.900.63-0.48
Debt / FCF Ratio
--34.940.97-0.60
Net Debt / Equity Ratio
-0.06-0.07-0.42-0.33-0.46-0.29
Net Debt / EBITDA Ratio
-0.57-0.60-3.61-1.47-1.78-2.03
Net Debt / FCF Ratio
0.230.27-137.77-2.25-1.69-2.53
Asset Turnover
0.530.550.610.831.050.61
Inventory Turnover
3.744.204.145.409.133.75
Quick Ratio
1.211.184.932.832.312.08
Current Ratio
1.571.505.453.242.612.45
Return on Equity (ROE)
8.86%9.71%10.37%18.50%21.11%10.28%
Return on Assets (ROA)
5.24%5.77%6.04%11.00%13.16%5.67%
Return on Invested Capital (ROIC)
9.04%12.18%15.31%26.03%33.32%13.67%
Return on Capital Employed (ROCE)
9.80%10.60%9.60%18.60%24.10%10.80%
Earnings Yield
6.47%6.71%5.64%7.10%8.53%5.90%
FCF Yield
-20.33%-19.00%0.19%5.98%11.87%6.44%
Dividend Yield
5.33%5.10%4.89%4.72%4.15%4.60%
Payout Ratio
82.01%75.89%103.24%42.00%29.71%120.85%
Buyback Yield / Dilution
0.47%-2.50%-15.70%--0.10%0.23%
Total Shareholder Return
5.82%2.60%-10.81%4.72%4.04%4.83%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.